MedTrace Logo

Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue

NCT02632929 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-07-27

No results posted yet for this study

Summary

The purpose of this study is to see whether the use of AMNIOEXCEL® improves healing and reduces the need to cut off all or part of a leg (amputation) in high-risk patients who have diabetes and foot sores (also sometimes called ulcers or wounds).

Conditions

  • Diabetic Foot Ulcer

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    collaborator INDUSTRY

  • Boise VA Medical Center

    lead FED

Principal Investigators

  • Margaret Doucette, D. O. · Boise VAMC

  • Kattie B Payne, PhD, RN, MSN · Boise VAMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-30
Primary Completion
2019-08-31
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02632929 on ClinicalTrials.gov